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The primary motor cortex (M1) is involved in ﬁne voluntary movements control. Previous
studies have shown the existence of a dopamine (DA) innervation in M1 of rats and
monkeys that could directly modulate M1 neuronal activity. However, none of these
studies have described the precise distribution of DA terminals within M1 functional
region nor have quantiﬁed the density of this innervation. Moreover, the precise role
of DA on pyramidal neuron activity still remains unclear due to conﬂicting results from
previous studies regarding D2 effects on M1 pyramidal neurons. In this study we assessed
in mice the neuroanatomical characteristics of DA innervation in M1 using unbiased
stereological quantiﬁcation of DA transporter-immunostained ﬁbers.We demonstrated for
the ﬁrst time in mice that DA innervates the deep layers of M1 targeting preferentially the
forelimb representation area of M1. To address the functional role of the DA innervation
on M1 neuronal activity, we performed electrophysiological recordings of single neurons
activity in vivo and pharmacologically modulated D2 receptor activity. Local D2 receptor
activation by quinpirole enhanced pyramidal neuron spike ﬁring rate without changes in
spike ﬁring pattern. Altogether, these results indicate that DA innervation inM1 can increase
neuronal activity through D2 receptor activation and suggest a potential contribution to the
modulation of ﬁne forelimb movement. Given the demonstrated role for DA in ﬁne motor
skill learning in M1, our results suggest that altered D2 modulation of M1 activity may
be involved in the pathophysiology of movement disorders associated with disturbed DA
homeostasis.
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INTRODUCTION
The primary motor cortex (M1) is involved in ﬁne voluntary
movements control and in novel motor skill learning (Hosp et al.,
2011). It integrates inputs from the premotor cortex and drives
excitatory outputs to the spinal cord and the basal ganglia via
glutamatergic pyramidal neurons. Dopamine (DA) indirect regu-
lation of motor function through the modulation of basal ganglia
activity has beenwidely described (Alexander et al., 1986; Lang and
Lozano, 1998; Murer et al., 2002; Dejean et al., 2012). In addition,
neuroanatomical studies have shown the existence of a direct DA
innervation from themidbrain toM1 that could directlymodulate
M1 neuronal activity (Descarries et al., 1987; Gaspar et al., 1991;
Raghanti et al., 2008).
Indeed, Gaspar et al. (1991) suggested the presence of such
an innervation in the most superﬁcial layers in human M1
using a tyrosine hydroxylase (TH) immunostaining to visualize
monoaminergic ﬁbers. In rats, Descarries et al. (1987) showed
a dopaminergic innervation in cortical areas such as the cingu-
late cortex (Cg), or in the deep layers of M1, by using 3H-DA
labeling. More recently, Hosp et al. (2011) described in rats
direct projections from the ventral tegmental area (VTA) to M1.
Although detectable dopaminergic tissue levels can be measured
in the motor cortex, this DA innervation remains weak compared
with other structures such as the striatum or nucleus accumbens.
For instance, Godefroy et al. (1991) showed that DA concentra-
tion in the somatomotor cortex is about 50 times lower than in
the striatum. However, the functional implication of DA in the
motor cortex and other cortical regions, such as the prefrontal
and cingulate cortices, has been well documented despite low
tissue and extracellular DA levels (Awenowicz and Porter, 2002;
Lopez-Avila et al., 2004; Schweimer and Hauber, 2006; Hosp et al.,
2009; Molina-Luna et al., 2009). DA acts via ﬁve different recep-
tors grouped in two classes, D1-like and D2-like, modulating
differentially adenylyl cyclase (Jaber et al., 1996). In the last three
decades, studies using in situ hybridization (Camps et al., 1990;
Mansour et al., 1990; Gaspar et al., 1995; Santana et al., 2009)
showed a wide distribution of the DA receptors in rodents. In
the cortex, D1 receptors are localized in the layer VI whereas D2
receptors are localized primarily in the layerV (Weiner et al., 1991;
Gaspar et al., 1995), which contains the principal output pathway
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to all other cortical areas and to subcortical targets as the stria-
tum or the pyramidal tract. Taken together, these data suggest that
DA receptors could play a direct role in modulating the activity
of M1.
Awenowicz and Porter (2002) and Huda et al. (2001) described
in vivo, respectively, in rats and cats, that DA application decreases
pyramidal neurons activity via both D1 and D2 receptors. More
recently, Hosp et al. (2009) showed a transient reduced excitabil-
ity of M1 mediated by the injection of a D2 antagonist, but not
a D1 antagonist, in rats in vivo. Moreover, speciﬁc dopaminergic
deafferentation of M1 impairs motor skill learning (Hosp et al.,
2011) and is associated with decreased long term potentiation
(LTP) that is mimicked by reversible blockade of D2 receptors
(Molina-Luna et al., 2009). These data suggest that D2 receptors
could potentiate basal activity of M1 neurons. Even though a DA
projection was reported in M1, the literature lacks quantiﬁcation
of this innervation. Moreover, functional studies are still conﬂict-
ing regarding the involvement of D1 receptors in the modulation
of M1 neuronal activity, and even though the literature agrees
on the involvement of D2 receptors, results diverge regarding
its excitatory or inhibitory effect on M1 activity. Unfortunately,
none of these studies was performed in mice; this is of interest
given the substantial number of transgenic mice models target-
ing the DA system and often used as models of psychiatric or
neurodegenerative disorders.
The aim of this study was to assess the neuroanatomical dis-
tribution of DA innervation in M1 in mice, and to evaluate the
functional role of this innervation onM1 neuronal activity. To this
end, we ﬁrst characterized anatomically DA ﬁber density in M1 by
using the DA transporter (DAT) as a speciﬁc marker of DA termi-
nals. In order to precisely quantify this innervation, we performed
an unbiased stereological quantiﬁcation of DAT labeled ﬁbers in
M1. Secondly, since all previous studies consensually point to an
involvement of D2 receptors in M1, we have tested the direct
inﬂuence of DA on M1 neuronal activity through this receptor.
For that purpose, we performed electrophysiological recordings
of M1 neuronal activity while pharmacologically modulating D2
receptors. Our study indicates that DA innervates M1 in mice
and is able to enhance the activity of pyramidal neurons in this
structure.
MATERIALS AND METHODS
ANIMALS AND SURGERY
All experiments were conducted in accordance with the guidelines
of the French Agriculture and Forestry Ministry (decree 87849)
and of European Union Directive (2010/63/EU). Adequate mea-
sures were taken to minimize animal pain as well as the number
of animals used. Female mice C57/BL6 (3–6months at the time of
experiments, Janvier, France) were housed in ventilated cages and
kept under a 12 h dark/light cycle. Animals had access to food and
water ad libitum.
Before surgery, mice were deeply anesthetized with Urethane
(1.8 g/kg) injected intraperitoneally (i.p.) before being secured
to a stereotaxic frame (LPC, France) and maintained at 37–38◦C
with a heating pad. A mouse brain stereotaxic atlas (Paxinos and
Franklin, 2001) was used to guide electrode and pipette place-
ments. Throughout the experiment, the efﬁciency of anesthesia
was determined by examining the tail pinch reﬂex. Additional
Urethane (0.25 g/kg, i.p.) was administered when necessary.
ELECTROPHYSIOLOGICAL PROCEDURES
Electrophysiological single unit activity was recorded in M1 using
electrodes pulled from borosilicate glass capillaries (GC 150 F,
Harvard Apparatus, England) with a P-97 Flaming Brown (Sut-
ter Instrument, USA). The tip of the electrode was broken to a
diameter of 2μm, and the electrode ﬁlled with a 0.4 MNaCl solu-
tion containing 2.5% neurobiotin (Vector Labs, USA). Electrodes
had an in vivo resistance of 12–20 M. Recording electrodes were
lowered in M1 (1.3–1.5 mm lateral and 1.0–1.5 mm anterior to
bregma) at a depth of between 0.65 and 1 mm from the brain
surface.
Neuronal activity was ampliﬁed 10 times, ﬁltered (bandwith:
300 Hz–10 kHz), and further ampliﬁed 100 times (Multiclamp
700-B, Axon Instruments, USA). The signal was digitized (Micro
1401mk II,Cambridge Electronics Design, England) and acquired
on computer using Spike 2 software. Recorded neurons were
juxtacellularly labeled with neurobiotin (Vector Labs, USA) as
described elsewhere (Pinault, 1996). Brieﬂy, positive 250 ms cur-
rent pulses were applied at 2 Hz with increasing currents (1–5 nA)
until driving cell ﬁring for at least 5 min. Immediately after
the neurobiotin injection, mice were transcardiacally perfused
with 0.9% NaCl and 4% paraformaldehyde (PFA). Brains were
collected and post-ﬁxed for 24 h at 4◦C in 4% PFA and cry-
oprotected overnight in 30% saccharose at 4◦C. Serial coronal
sections (40 μm) containing M1 were cut using a cryostat (CM
3050 S, Leica, Germany). To reveal neurobiotin, sections were
rinsed three times in 0.1 M phosphate buffer saline (PBS), pro-
cessed for 1 hwith a blocking solution (3%bovine serumalbumine
(BSA), 0.3% Triton X-100 in PBS) and incubated overnight at 4◦C
within Streptavidin Alexa 568 (Invitrogen, USA) diluted 1:800 in
PBS containing 3% BSA and 0.3% Triton X-100. Sections were
then rinsed three times in PBS before being mounted on gelatin
coated-slides, air-dried and coverslipped with DePeX (VWR,
USA).
Antidromic stimulationof the striatum ipsilateral to the record-
ing site was performed using a concentric bipolar electrode
(SNEX-100, Rhodes Medical Instruments, USA) implanted in the
dorsolateral striatum (2 mm lateral and 0.2 mm anterior to the
bregma, depth of 1.85 mm from the brain surface). Electrical
stimulations (0.5 ms, 600–800μA) were applied every 5 s using an
external stimulator (DS3; Digitimer, England) triggered by a 1401
Plus system (Cambridge Electronic Design, England).
DRUG APPLICATION
Systemic administration of D2 pharmacology was performed
through an i.p.-implanted-needle connected to a syringe ﬁlled
either with a D2 agonist (quinpirole, 0.5 mg/kg, Sigma, USA), D2
antagonist (haloperidol, 0.5 mg/kg, Sigma, USA) or 0.9% NaCl.
Drug injections were performed after a 30 min baseline record-
ing and electrophysiological activity was monitored for 45 min
following the injection.
Local intracortical drug administration was performed using
a glass pipette pulled from a glass capillary (GC 100 FS, Har-
vard Apparatus, England) ﬁlled with either quinpirole 100 μM,
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quinpirole 1 μM or artiﬁcial cerebrospinal ﬂuid (ACSF) that was
lowered close to the tip of the recording pipette. After a 5min base-
line recording, the drug was applied by air pressure and neuronal
ﬁring was monitored for another 15 min.
ANALYSIS OF ELECTROPHYSIOLOGICAL DATA
The recordings were analyzed ofﬂine. Action potential (AP) dura-
tion was measured from the time when AP begins to the time
when baseline is recovered. In order to assess the pharmacologi-
cal modulation of neuronal activity, AP ﬁring rate was analyzed
before and after pharmacological treatments of 10 min or 1 min
durations, respectively, for i.p. and intracortical drug injection.
AP durations, neuron responsiveness to striatal stimulation, and
ﬁring frequencies were analyzed using Spike 2 7.0 (Cambridge
Electronics Design, England). AP ﬁring patterns were analyzed
using NeuroExplorer burst analysis (maximum interval to start a
burst = 40 ms, maximum interval to end a burst = 10 ms, min-
imum interval between bursts = 20 ms, minimum duration of a
burst = 5 ms and minimum number of spikes in a burst = 2).
IMMUNOHISTOCHEMICAL PROCEDURES
Three mice were deeply anesthetized with chloral hydrate
(400 mg/kg). They were then perfused transcardiacally with 0.9%
NaCl and 1% PFA. Brains were removed, post-ﬁxed in 1% PFA
at 4◦C for 24 h and cryoprotected overnight in 30% saccharose.
Brains were serially cut in six sets of coronal sections (40 μm)
using a vibratingmicrotome (MICROMHM650V,ThermoScien-
tiﬁc, France). Free-ﬂoating sections were kept at −20◦C in glucose
0.19%, ethylene glycol 37.5% and sodium azide 0.25% in PBS
0.05 M.
For each brain, one of the six sets of sections was randomly
chosen for DAT immunohistochemical processing. Sections were
rinsed three times in 0.1 M Tris-buffered saline (TBS), treated
with 0.6%H2O2 in TBS for 15min, rinsed three times in TBS, and
incubated for 90 min in blocking solution (10% donkey serum,
0.3% triton X-100 in TBS). Sections were incubated for 48 h at
4◦C with primary antibody (rabbit anti-DAT, 1:5000, gift from
Pr Bertrand Bloch, CNRS UMR5293) diluted in blocking solu-
tion. Sections were rinsed three times in TBS and incubated for
1 h in the secondary antibody (donkey anti-rabbit biotin SP, Jack-
son Immuno Research, USA) diluted 1:500 in TBS containing 5%
donkey serum and 0.3% triton X-100. Sections were rinsed three
times in TBS, incubated in 0.5% avidin–biotin complex (Vector
Labs, USA) in TBS, rinsed three times in TBS and processed with
3-3′-diaminobenzidine (Sigma, USA) and 0.33% H2O2. Sections
weremounted, air-dried, and coverslipped inDePeX (VWR,USA).
STEREOLOGICAL ANALYSIS
Cingulate cortex was deﬁned anteriorly from 2.58 mm to the
bregma to posteriorly −0.82 mm to the bregma, as deﬁned by
Paxinos and Franklin (2001). The medial boundaries are deﬁned
by the medial line of the brain and the lateral boundaries are
deﬁned by the presence of horizontal cortical layers. M1 was
deﬁned anteriorly from 1.1 mm bregma to posteriorly −0.94 mm
to the bregma from layers I to VI, as deﬁned in a stereotaxic atlas.
The relatively narrow layer IV and thick layer V deﬁned the lateral
and medial boundaries of M1, and ventral boundaries consisted
of the most dorsal part of the corpus callosum. The deep layers
of M1 were deﬁned as the most ventral half of M1 (from 500 μm
to the surface to the dorsal outline of the corpus callosum), as
deﬁned by Lev andWhite (1997). For the total number of sections
containing M1, we sampled every sixth section, starting with a
section randomly selected from the ﬁrst six sections, to generate
a set of distributed sections within each sample. After the DAT
immunohistochemistry, the average ﬁnal thickness of the sections
was 11.97 ± 0.38 μm (i.e., a shrinkage of ∼70% during pro-
cessing). The stereological analysis used was described previously
by Mouton et al. (2002). Each section was scanned by a camera
(Orca-R2, Hamamatsu Electronic, Japan) connected to a micro-
scope (DM 5500, Leica, Germany). Then, virtual sphere probes
were scanned on the Z axis of M1 and Cg using the Mercator
Software (Explora Nova, France). Each sphere was 4 μm radius
and contained in a 10 μm × 10 μm square, spacing between each
square was 50 μm × 50 μm. Spheres were visualized as a series
of concentric circles of changing circumferences upon focusing
through the tissue. Finally, the intersections between the outline
boundary of the sphere and the ﬁbers were counted at each focal
plane. To avoid artifacts due to border effects, upper and lower
guard zones of 1 μm were kept for each section. The total length
of ﬁbers is calculated according to the following equation:
L = 2 · Q[v/a]F1 · F2 · F3
where L = total length of linear feature (in μm), Q = sum
intersections between ﬁbers and spheres, F1 = 1/section sampling
fraction (1/6), F2 = 1/area sampling fraction, F3 = 1/thickness
sampling fraction, v/a = the ratio of the volume of one sampling
box to the surface area of one spherical probe. All values are given
as the mean ± SE. Calculated values are corrected for the 70%
shrinkage due to section processing.
DETERMINATION OF THE DOPAMINERGIC FIBERS DISTRIBUTION
WITHIN M1
To determine the rostrocaudal and mediolateral extent of
dopaminergic ﬁberswithinM1,photomicrographsof sections that
previously underwent stereological analysis were used to deter-
mine the surface area occupied by DAT labeled ﬁbers. On each
section, the results were plotted as the occupied surface inμm2 rel-
ative to the anteroposterior axis. Measures were performed using
ImageJ 1.47v.
STATISTICAL ANALYSIS
Statistical analyses were performed using the Mann–Whitney test
for independent data, and a two-way ANOVA with Bonferroni
posttests when comparing drugs effect over time.
RESULTS
ANATOMICAL DISTRIBUTION OF THE DOPAMINERGIC TERMINALS
IN M1
DA ﬁbers were labeled using DAT immunostaining in order to
visualize the dopaminergic innervation in M1 (Figures 1A,B,D)
and Cg (Figures 1C,E). Dopaminergic ﬁbers were present in the
deep layers of M1. In M1 and Cg, these ﬁbers were long, tortu-
ous and thin with tangles and branches. Stereology was used to
precisely evaluate the extent of this innervation.
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FIGURE 1 | Anatomical distribution of the dopaminergic terminals in
M1. (A–C) Example of the delimitation of cortical regions: M1 (A; green
line), M1 deepest layers (B; yellow line) and Cg (C; blue line). (D–E)
Photomicrographs of DAT immunostained ﬁbers (black arrows) in M1
deepest layers (D) and Cg (E). (D) and (E) were obtained from higher
magniﬁcation of the region contained in the red box shown in (A) and
(C), respectively. (F) Rostrocaudal repartition of DAT immunostained ﬁbers
in M1, the labeled superﬁcies are represented for each level according to
Bregma. The colors from light to dark orange code for the size of the
labeled area, this color code is used to represent on the schematic sagittal
section of mouse brain the distribution of these areas in the motor cortices
(blue line delineates M2 and M1). (G) Distribution of the DAT labeled ﬁbers
at the surface of the cortex. The blue line represents delimitation of M1,
the red area represents DAT immunostained ﬁbers within M1. Scale bars
represent 100 μm (A–C) and 12.5 μm (D–E).
Themean total length of dopaminergic ﬁberswas 1.89± 0.22m
in M1 and 3.64 ± 0.56 m in Cg. The dopaminergic innervation
density, calculated as the result of the total ﬁbers length divided
by the volume of the structure, was 0.54 ± 0.01 m/mm3 in M1
and 2.18 ± 0.20 m/mm3 in Cg. Thus, according to this stereolog-
ical approach, DA innervation is 4.4 times higher in Cg than in
M1. However, since the dopaminergic ﬁbers in M1 were found
mostly in the deep layers (Figure 1D), we performed a stere-
ological quantiﬁcation of the dopaminergic innervation in the
deep layers of M1 deﬁned as the deepest half of M1 (Figure 1B).
Total dopaminergic ﬁbers length in the deep layers of M1 was
1.39 ± 0.06 m. This length is not statistically different from the
total length of dopaminergic ﬁbers found in the entire volume of
M1 (p = 0.097), conﬁrming our initial observation that dopamin-
ergic terminals in this structure are mostly restricted to the deep
cortical layers. The density of DA terminals in the deep layers of
M1 was then estimated to 1.38 ± 0.17 m/mm3. Therefore, when
restricting the analysis to the speciﬁc region innervated by DA in
M1, the dopaminergic innervation density is of the same order of
magnitude as in Cg.
To further characterize the neuroanatomical distribution of
dopaminergic innervation, we measured the distribution of DA
ﬁbers within M1. Differences appeared in the rostrocaudal distri-
bution of DA ﬁbers. Indeed, the area innervated by DA ﬁbers
is maximal between 0.2 and 1.10 mm anterior to the bregma
(Figure 1F). Furthermore, regarding the mediolateral distribu-
tion of dopaminergic ﬁbers in M1 (Figure 1G), we observed that
only this area, which corresponds to the forelimb representation
area (Tennant et al., 2011), is innervated on thewholemediolateral
extend of the structure.
Altogether, these data show that DA innervates the deep layers
of mouse M1 with a rostrocaudal gradient. The density of this
innervation in M1deep layers is comparable to that of Cg. It has
been well described that DA could modulate Cg neuronal activity
(Lopez-Avila et al., 2004; Schweimer andHauber, 2006). Thus, our
results further suggest that the density of DA innervation in M1
deep layers could be sufﬁcient to signiﬁcantly impact neuronal
activity.
ELECTROPHYSIOLOGICAL CHARACTERISTICS OF RECORDED NEURONS
We addressed the functional role of D2 receptors on M1 neu-
ronal activity by electrophysiological single unit recordings in
anesthetized mice (Figure 2A). Ninety-seven neurons in 56 mice
were recorded in deep layers (Figure 2B). In order to investigate
D2 effects on M1 output neurons, we focused our experiments
on pyramidal neurons, although local-circuit inhibitory neurons
are also present (Markram et al., 2004). Previous studies have
established the electrophysiological characteristics of pyramidal
neurons in rat prefrontal cortex (PFC). Pyramidal neurons exhibit
low ﬁring frequencies (between 0.1 and 5 Hz; Hajos et al., 2003)
and AP durations above 0.95 ms (Mallet et al., 2005; Tseng et al.,
2006). We analyzed these physiological characteristics in the 97
neurons recorded in this study; however, in our conditions, no
clear bi-modal distribution emerged from this analysis that would
have allowed to discriminate between cortical neuronal popula-
tions (inhibitory interneurons and excitatory pyramidal neurons;
Figure 2C). Regarding ﬁring patterns, we found that 83 neurons
presented doublets or triplets (Figure 2A) and a bursty discharge
pattern (34.47 ± 2.44% of spikes in burst). In order to determine
an inclusion criteria speciﬁc to our experimental conditions, we
analyzed the electrophysiological characteristics of neurons iden-
tiﬁed as projection neurons by their antidromic response to the
stimulation of the ipsilateral striatum (Figure 3A). Neurons that
presented antidromic responses were considered as pyramidal.We
recorded nine antidromically responding neurons and four neu-
rons that did not respond to the striatal stimulation. Responsive
and non-responsive neurons were statistically different regarding
their ﬁring pattern (p < 0.01). Indeed, all neurons responding to
the antidromic stimulation presented at least 25% of their spikes
in bursts (ranging from 25 to 68%) whereas the non-responding
neurons presented at most 8.8% of their spikes in bursts (ranging
from 0 to 8.8%; Figure 3B). Thus, in our experimental conditions,
the percentage of spikes in bursts is the best electrophysiological
characteristic to consider a neuron as a pyramidal one. Using
this characteristic as a criterion, 30 neurons presenting at least
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FIGURE 2 | Electrophysiological characteristics of M1 neurons.
(A) Representative electrophysiological trace of a cortical neuron. Note the
presence of triplet of spikes (black arrows). The inset represents the action
potential shape (averaged over 5 min recording), the action potential
duration is measured between the two dashed lines. (B) Schematic
representation of the distribution of recorded neurons in M1 1.4 mm
anterior to Bregma, neurobiotine labeled neurons (red dots) and non
labeled neurons (black dots). Photomicrograph shows a representative
example of neurobiotine labeled neuron. Scale bar represents 20 μm.
(C) Distribution of the mean frequency (Hz) and AP duration (ms).
15% spikes in burst were included in the study and referred to as
“putative pyramidal neurons”.
EFFECTS OF DOPAMINE D2 RECEPTOR AGONIST AND ANTAGONIST ON
PUTATIVE PYRAMIDAL NEURON ACTIVITY IN M1 In Vivo
To study the effects of DA on M1 neuronal activity, we recorded
AP ﬁring rate of putative pyramidal neurons in the deep layers
of M1 and their response to the D2 agonist quinpirole or the
D2 antagonist haloperidol. We ﬁrst performed intraperitoneal
(i.p.) injections of quinpirole (0.5 mg/kg; n = 5), haloperi-
dol (0.5 mg/kg; n = 5) or saline 0.9% (n = 5; Figure 4). D2
receptor activation by quinpirole enhanced putative pyramidal
neurons ﬁring rate by more than 200% (from 1.46 ± 0.39 Hz to
3.44± 0.81Hz, twowayANOVA F(2,60) = 15.11, p < 0.001). There
was no statistically signiﬁcant effect of D2 receptors blockade by
haloperidol on AP ﬁring rate.
These effects could be due to a network effect, particularly
via the basal ganglia. To avoid the indirect network effects of
DA and address the direct effect of D2 activation on M1 activ-
ity, we performed intracortical injections of quinpirole 100 μM,
quinpirole 1 μM or ACSF (Figures 5A,B). Due to absence of sig-
niﬁcant modiﬁcations after i.p. injections of haloperidol, we did
not test the pyramidal neuron responses to intracortical injec-
tions of the D2 antagonist. Consistent with the results obtained
after i.p. injections, local D2 receptor activation by quinpirole
(100 or 1 μM) enhanced putative pyramidal neurons ﬁring rate
(respectively: Two way ANOVA F(4,28) = 5.24, p < 0.001; Two
way ANOVA F(4,36) = 3.98, p < 0.01). Quinpirole (1 μM) also
increased spike ﬁring rates from 1.53 ± 0.44 Hz to 2.47 ± 0.62 Hz
(Figure 5C). Furthermore, analysis of neuronal AP ﬁring pat-
tern revealed that the number of bursts, but not the percentage
of spikes in burst, was increased by D2 receptors activation (data
not shown). These results indicate that DA can enhance pyra-
midal neuron ﬁring rates, but does not modulate ﬁring patterns.
Taken together, these results show that DA exerts a direct role on
M1 neuronal activity by enhancing neuronal ﬁring rate via D2
receptors.
DISCUSSION
In this study, we demonstrated for the ﬁrst time in mice that
DA innervates the deep layers of M1. We also established
that these ﬁbers target preferentially the forelimb representa-
tion area of M1. To address the functional role of DA on
M1 neuronal activity, we performed electrophysiological record-
ings of single neuron activity in vivo and pharmacologically
modulated D2 receptors. We demonstrated that D2 receptor
activation by quinpirole enhanced pyramidal neuron spike ﬁr-
ing rates. Our results also show that this increase was not
due to an extracortical network effect, but is locally mediated
in M1.
ANATOMICAL CHARACTERIZATION OF DA INNERVATION OF M1 IN
MICE
Although TH immunolabeling is commonly used to reveal
dopaminergic ﬁbers (Gaspar et al., 1991; Busceti et al., 2008), TH is
an enzyme common to all catecholamines synthesis, and such does
not allow one to distinguish between adrenergic and dopaminer-
gic ﬁbers. Thus, to speciﬁcally target dopaminergic ﬁbers, we used
a DAT antibody. DAT distribution has already been shown to be
restricted to dopaminergic regions (Ciliax et al., 1995). Our results
in mice showing the existence of a dopaminergic innervation of
M1 are in accordance with previous studies conducted in different
species including rat (Descarries et al., 1987), monkey (Raghanti
et al., 2008) and human (Gaspar et al., 1991; Raghanti et al., 2008).
Moreover, this study provides for the ﬁrst time a precise and direct
quantiﬁcation of this innervation inM1 and Cg using an unbiased
stereological approach. This quantiﬁcation allowed us to precisely
detail the distribution of DA ﬁbers at different levels of M1. Our
data complement previous observations by showing that the den-
sity of dopaminergic innervation is similar in the deep layers of
M1 and in Cg. The functional signiﬁcance of DA in Cg has been
well established (Lopez-Avila et al., 2004). Previous studies show-
ing the existence of D1 andD2 receptors inM1 (Camps et al., 1990;
Mansour et al., 1990; Gaspar et al., 1995; Santana et al., 2009),
together with our present results, provide anatomical evidence
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FIGURE 3 | Electrophysiological characteristics of antidromically
identified neurons. (A) Representative electrophysiological recording trace
of a cortical neuron responding to the striatal stimulation by an antidromic
spike (left). The occurrence of a spontaneous AP just before the stimulation
collides with the antidromic spike resulting in the absence of the antidromic
response after the stimulation (right). (B) Neurons were divided in two groups
according to their response (black dots) or not (white dots) to the striatal
stimulation, the graphs show the individual data (large dots) as well as the
mean ± SEM of electrophysiological characteristics: Mean frequency (Hz), AP
duration (ms) and percentage of spikes included in a burst (%). **p < 0.01.
FIGURE 4 | D2 modulation of M1 neuronal activity. (A) Effect of a
peripheral injection of D2 agonist quinpirole (n = 5, black) or D2 antagonist
haloperidol (n = 6, grey) or NaCl 0.9 % (n = 5, white) on putative pyramidal
neurons ﬁring frequency. (B) Individual responses of putative pyramidal
neurons to the D2 agonist. **p < 0.01; ***p < 0.001.
suggesting that DA can exert a direct inﬂuence onto M1 neuronal
activity.
DA MODULATION OF M1 NEURONAL ACTIVITY IN VIVO
We investigated the hypothesis that DA directly modulates
M1 activity using single unit electrophysiological recordings in
anesthetized mice and showed that DA has a direct inﬂuence on
putative pyramidal neuron activity in M1. In our experiments, D2
receptor activation increased neuronal spike ﬁring rate by enhanc-
ing the number of spikes, but not the percentage of spikes in
bursts. Our results are consistent with a previous study showing
in rats that a local injection of haloperidol induced an increase
of motor threshold and a reduced size of motor maps, suggesting
an excitatory role of D2 receptor activation in M1 (Hosp et al.,
2009).
Awenowicz and Porter (2002) previously reported the involve-
ment of the two types of DA receptors in a synergistic manner
in rat motor cortex. Their study showed a global inhibitory effect
in pyramidal neuron activity following iontophoretic DA (0.1 M)
administration. The discordance between their results and ours
could be explained by the difference in the local injection proce-
dure (iontophoresis versus pressure ejection). Although this study
showed a DA effect on M1 electrophysiological activity, one must
consider the possible electrophysiological perturbations in neu-
ronal activity induced by iontophoresis injection. Indeed, it was
recently shown that high current injections near neurons can lead
to decreased neuronal ﬁring rates (Moore et al., 2011).
Our results showing enhanced putative pyramidal neuron
activity after D2 receptor activation are consistent with the ﬁnding
that quinpirole acting on D2 receptors increases the excitability
of layer V pyramidal neurons in the PFC of adult mice (Gee
et al., 2012). This study, performed in brain slices, demonstrated
an excitatory effect of D2 receptor activation on PFC pyrami-
dal neurons by the induction of a calcium-channel-dependent
after-depolarization.
However, other scenarios might also contribute to the effects of
D2 agonists on motor cortex excitability. On one hand, DA effects
on putative pyramidal neuron activity might be local, but indirect
via the modulation of cortical inhibitory interneurons. Indeed, in
primate PFC, DA axons establish direct contacts with interneu-
rons expressing parvalbumin (Sesack et al., 1998). More recently,
Santana et al. (2009) reported that inhibitory interneurons in
rats PFC express D1 and D2 receptors. Moreover, electrophys-
iological studies from mice and rat PFC slices suggest that D2
receptor activation inhibits GABA interneurons (Xu and Yao,
2010), resulting in a decreased GABA release probability and
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FIGURE 5 | Intracortical injection of D2 agonist quinpirole or ACSF.
(A) Typical recording of a putative pyramidal neuron 30 s before and 40 s
after an injection of ACSF (upper panel), 1 μM (middle panel) or 100 μM
quinpirole (lower panel). (B) Effect of an injection of ACSF on the mean
AP ﬁring frequency of putative pyramidal neurons (n = 5) in white. Effect
of an injection of 100 μM quinpirole on the mean AP ﬁring frequency of
putative pyramidal neurons (n = 4) in black. Effect of an injection of 1 μM
quinpirole on the mean AP ﬁring frequency of putative pyramidal neurons
(n = 6) in grey. (C) Individual responses of putative pyramidal neurons to
1 μM quinpirole. (A) The vertical black line represents the injection. (B)
**p < 0.01; ***p < 0.001.
a reduction of inhibitory postsynaptic currents (Seamans et al.,
2001). Although these studies were conducted in prepubertal
animals, they suggest that D2 receptor agonists could decrease
the activity of inhibitory interneurons, thus indirectly enhancing
pyramidal neuron activity.
On the other hand, DA effects observed in this study might be
exerted directly on pyramidal neurons. Indeed, a recent study in
PFC showed that pyramidal neurons in rats express the D2 recep-
tor mRNA (Santana et al., 2009). Thus, DA may directly enhance
pyramidal neuron activity by activating D2 receptors.
Additionally, our pharmacological data cannot rule out an
effect of D2 agonists on D2 autoreceptors on dopaminergic ter-
minals. The presynaptic modulation of DA release by D2 agonists
might induce postsynaptic D1 as well as D2 receptor modulation.
However, in our conditions, since the D2 agonist would directly
stimulate the postsynapticD2 receptors, the presynaptic inhibition
of DA release would mainly result in a decrease of D1 receptors
stimulation.
FUNCTIONAL AND PATHOLOGICAL CONSIDERATIONS
Finally, it is interesting to note that our study shows that DA
innervation in mouse M1 speciﬁcally targets an area that corre-
sponds to the forelimb representation (Tennant et al., 2011). DA
in motor cortex is known to regulate novel motor skill learning
(Molina-Luna et al., 2009; Hosp et al., 2011). Furthermore, recent
studies in rats showed that unilateral disruption of DA projec-
tions to M1 leads to a reduction of forelimb representation map
associated with a reduction of intracortical microstimulation-
induceddistal forelimbmovements (Viaro et al., 2011) and impairs
motor skill learning (Molina-Luna et al., 2009; Hosp et al., 2011).
Thus, these studies suggest a potential role of DA in the modula-
tion of forelimb representation in M1. Considering pathological
conditions, patients with de novo Parkinson’s disease (PD), a neu-
rodegenerative disorder caused mainly by disruption of the DA
nigrostriatal pathway, show abnormally high grip force in a pre-
cision lifting task (Fellows and Noth, 2004). Moreover, Gaspar
et al. (1991) have shown that PD patients have altered dopamin-
ergic innervation of motor cortex. Disruption of ﬁne motor
skills may involve the degeneration of dopaminergic terminals in
M1. Taken together, these results suggest a role for DA in ﬁne
motor skill control of forelimb. Interestingly, studies on human
M1 also reported that LTP cannot be induced in PD patients
(Morgante et al., 2006) as long as they are off dopaminergic med-
ication (Huang et al., 2011). Furthermore, Morgante et al. (2006)
indicated that abnormal motor cortex plasticity may underlie
the development of L-DOPA induced dyskinesia in PD patients.
These results suggest that DA could be a key component in M1
plasticity.
CONCLUSION
In conclusion, our study provides for the ﬁrst time a precise
description of the dopaminergic projections to M1 in mice, with
a stereological quantiﬁcation of DA innervation density and ﬁber
distribution within M1. In addition, we show an increased puta-
tive pyramidal neurons ﬁring activity induced by local D2 agonist.
The exact mechanisms of this modulation remain to be eluci-
dated and the role of D1 receptors has yet to be considered.
Nevertheless, these results constitute a new step towards under-
standing the mechanisms by which DA modulates M1 activity
and suggest that altered local D2 modulation may be involved
in pathophysiological conditions associated with disturbed DA
homeostasis.
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